Pramlintide Combined With Model Predictive Control Algorithm

Summary

This is a scientific research study that will look at how a "closed-loop" system and the drug Pramlintide may work together to improve blood sugar control in people with type 1 diabetes mellitus. Pramlintide is approved by the Food and Drug Administration (FDA) and is given as an injection (subcutaneous) that works with insulin to lower blood sugar.

Timeline

Start

2011-02

Primary completion

2012-02

Completion

2012-02

Outcome

Outcome not reported

Stopped: “Modified study; created new study as a result of these modifications”

Drugs

Indications